GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai HeartCare Medical Technology Corp Ltd (HKSE:06609) » Definitions » ROC (Joel Greenblatt) %

Shanghai HeartCare Medical Technology (HKSE:06609) ROC (Joel Greenblatt) % : -1.44% (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Shanghai HeartCare Medical Technology ROC (Joel Greenblatt) %?

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Shanghai HeartCare Medical Technology's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was -1.44%.

The historical rank and industry rank for Shanghai HeartCare Medical Technology's ROC (Joel Greenblatt) % or its related term are showing as below:

HKSE:06609' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -501.86   Med: -169.12   Max: -15.43
Current: -15.43

During the past 5 years, Shanghai HeartCare Medical Technology's highest ROC (Joel Greenblatt) % was -15.43%. The lowest was -501.86%. And the median was -169.12%.

HKSE:06609's ROC (Joel Greenblatt) % is ranked worse than
56.47% of 850 companies
in the Medical Devices & Instruments industry
Industry Median: -0.525 vs HKSE:06609: -15.43

Shanghai HeartCare Medical Technology's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


Shanghai HeartCare Medical Technology ROC (Joel Greenblatt) % Historical Data

The historical data trend for Shanghai HeartCare Medical Technology's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai HeartCare Medical Technology ROC (Joel Greenblatt) % Chart

Shanghai HeartCare Medical Technology Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
ROC (Joel Greenblatt) %
-253.84 -501.86 -169.12 -76.41 -30.74

Shanghai HeartCare Medical Technology Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only -78.99 -109.34 -32.07 -29.00 -1.44

Competitive Comparison of Shanghai HeartCare Medical Technology's ROC (Joel Greenblatt) %

For the Medical Devices subindustry, Shanghai HeartCare Medical Technology's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai HeartCare Medical Technology's ROC (Joel Greenblatt) % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai HeartCare Medical Technology's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Shanghai HeartCare Medical Technology's ROC (Joel Greenblatt) % falls into.



Shanghai HeartCare Medical Technology ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(84.126 + 159.734 + 57.067) - (42.509 + 0 + 17.507)
=240.911

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(91.542 + 162.025 + 8.6490000000001) - (35.176 + 0 + 24.327)
=202.713

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Shanghai HeartCare Medical Technology for the quarter that ended in Jun. 2024 can be restated as:

ROC (Joel Greenblatt) %(Q: Jun. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Jun. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-4.958/( ( (109.024 + max(240.911, 0)) + (137.095 + max(202.713, 0)) )/ 2 )
=-4.958/( ( 349.935 + 339.808 )/ 2 )
=-4.958/344.8715
=-1.44 %

Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai HeartCare Medical Technology  (HKSE:06609) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Shanghai HeartCare Medical Technology ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Shanghai HeartCare Medical Technology's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai HeartCare Medical Technology Business Description

Traded in Other Exchanges
N/A
Address
No. 356, Zhengbo Road, Floor 1 and 3, Building 38, Pilot Free Trade Zone, Lingang New District, Shanghai, CHN
Shanghai HeartCare Medical Technology Corp Ltd is an innovative neuro-interventional medical device company. The company is committed to creating high-quality products for the prevention and treatment of stroke. Geographically, the Group's revenue is derived from Mainland China.
Executives
Ding Kui 2201 Interest of corporation controlled by you
Wisary Limited 2101 Beneficial owner
Wang Guohui
Shanghai Zandaqian Enterprise Management Consulting Center
Lyfe Capital Management Limited
Lyfe Capital Fund Iii (dragon), L.p.
Shanghai Weiyun Enterprise Management Consulting Partnership (lp)
Lyfe Columbia River Limited
Temasek Holdings (private) Limited
Elbrus Investments Pte. Ltd.
Fullerton Management Pte Ltd
Temasek Life Sciences Private Limited

Shanghai HeartCare Medical Technology Headlines

No Headlines